Clinical Laboratory

Healgen Scientific LLC is a global in-vitro diagnostics (IVD) developer and manufacturer established in 2007 in Houston, Texas. The company specializes in rapid point-of-care (POC) diagnostic testing technologies across multiple therapeutic areas: infectious diseases (COVID-19, influenza, Strep A), toxicology (drug screening, fentanyl/xylazine residue detection), fertility and women's health, oncology, cardiovascular, and metabolic disorders. Healgen's product portfolio includes rapid test cassettes, cups, and oral fluid devices—many FDA 510(k) cleared and CLIA-waived. Notable products include the Accurate® Multi-Drug Urine Drug Screen Cup (18-in-1 detection), Rapid Check® COVID-19/Flu A&B Antigen Test (available for both professional and OTC use), Fentanyl Rapid Tests, Strep A tests, and recently FDA De Novo-cleared Accurate® Oral Fluid Device. The company markets solutions to healthcare providers, workplace testing programs, public health organizations, and consumers. Healgen maintains global service centers and business partnerships across multiple countries and regions. Manufacturing and quality systems support FDA and international regulatory compliance.

RICCA Chemical Company LLC is a laboratory chemical supplier serving clinical, environmental, and production laboratory markets. The company manufactures and distributes a comprehensive line of chemicals, calibration standards, and certified reference materials (CRMs) designed to meet stringent analytical and quality-control requirements. Product offerings include pH buffer solutions, conductivity standards, ion chromatography (IC) standards, and PFAS (per- and polyfluoroalkyl substances) certified reference materials. RICCA emphasizes tight specifications and minimal lot-to-lot variability as competitive differentiators. The company holds ISO 9001:2015 certification for quality management and maintains ISO/IEC 17025 and ISO Guide 17034 accreditations for reference material production and testing laboratory competence. These accreditations underscore compliance with international standards for analytical measurement and traceability. RICCA serves laboratories requiring calibration standards for environmental testing, food safety, water quality analysis, and instrument calibration across multiple analytical techniques. The company offers custom chemical solutions tailored to specific instrument and application requirements. Online platforms include product search functionality, certificate-of-analysis lookup, and safety data sheet (SDS) access, supporting procurement efficiency for institutional and industrial customers.

GenDx is a science-based molecular diagnostics company specializing in HLA typing and transplantation diagnostics. The company develops and markets pre- and post-transplant reagent kits, NGS-based HLA typing solutions, and proprietary laboratory software for clinical diagnostics. Product lines include NGSgo-AmpX (next-generation sequencing HLA typing kits for various gene targets including HLA-DRB1, DQB1, and DPB1) and complementary software platforms known for reliability, intuitive navigation, and rapid analysis. GenDx serves transplant laboratories, biobanks, and research institutions globally, with particular emphasis on user-friendly workflows and technical support. The company offers world-class customer support, educational events, and training programs for end users at all proficiency levels. GenDx appears to operate as part of a larger acquisition ecosystem, as evidenced by recent press releases regarding CareDx's transplant lab product division. The company maintains a strong focus on molecular diagnostics quality, laboratory efficiency, and continuous innovation in companion diagnostics and precision medicine applications.

cyberDERM, inc. is a specialized manufacturer of noninvasive biomedical instrumentation and imaging systems for objective skin measurement and analysis. The company develops and refines innovative bio-instrumental and photographic methods for assessing skin structure, function, and the effects of topical treatments. They serve dermatology, cosmetics, pharmaceutical, and clinical research markets with a focus on clinical claim substantiation and instrument development. Product lines include ultrasound-based skin analysis systems (DermaScan C at 20 MHz and 50 MHz), colorimetry devices (Skin Colorimeter DSM-4), and comprehensive skin parameter measurement platforms (DermaLab Single and DermaLab Combo) that measure hydration, elasticity, TEWL (transepidermal water loss), subcutaneous structure, skin color, temperature, pH, sebum levels, and videomicroscopy. The company maintains a Technical Center in Broomall, PA for equipment service and calibration. cyberDERM has built an international reputation for cost-effective, innovative instrumentation meeting the specific needs of contract research organizations, cosmetic companies, pharmaceutical firms, and academic institutions conducting skin efficacy studies and product development.

AB Sciex LLC is a global leader in mass spectrometry and capillary electrophoresis solutions for research, clinical diagnostics, and life sciences applications. The company manufactures a comprehensive portfolio of analytical instruments including triple-quadrupole and QTOF mass spectrometers, HPLC-MS systems, and capillary electrophoresis (CE) instruments. SCIEX serves clinical diagnostic laboratories with FDA-cleared in vitro diagnostic (IVD) medical devices for routine testing; pharmaceutical and biopharmaceutical companies for drug development and biologics characterization; contract research organizations for bioanalysis; environmental and food safety testing facilities; and life science research institutions. Core product lines include the Triple Quad 7500 Plus system, ZenoTOF 7600 QTOF system, Citrine clinical IVD mass spectrometers, ExionLC front-end HPLC systems, and Intabio ZT for charge variant analysis. SCIEX OS is the company's proprietary software platform supporting Windows 11 for data acquisition, processing, and instrument control. The company emphasizes speed, sensitivity, resolution, and ease of adoption across routine and complex analytical workflows. Manufacturing and support operations span multiple global regions, with primary headquarters in Marlborough, MA, and sales/service in Redwood City, CA (Americas) and multiple EMEA locations.

ResearchDx is a comprehensive diagnostic development and contract research organization (CRO) specializing in in vitro diagnostic (IVD) test development, validation, and commercialization. The company operates three integrated divisions: Contract Services (biomarker discovery, assay development, regulatory filings); Diagnostic Laboratory (CLIA/CAP/ISO 15189 accredited clinical testing under the PacificDx brand); and Diagnostic Manufacturing (ISO 13485:2016 and GMP-compliant kit manufacturing under the CustomDx brand). Core capabilities include custom molecular assay development (PCR, qPCR, ddPCR, NGS, microRNA, protein, flow cytometry, ELISA), analytical and clinical validation, companion diagnostic development, and complete laboratory accreditation consulting. The company is ISO 13485:2016 certified, CLIA approved, CAP accredited, and FDA registered. Recent achievements include FDA 510(k) clearances for GlutenID celiac genetic health risk test and regulatory approvals for companion diagnostics (ProMarkerD for diabetic kidney disease, FibroSIGHT for MASH liver fibrosis detection). ResearchDx serves pharmaceutical companies, diagnostic startups, and established laboratories requiring integrated IVD development from concept through commercialization and contract manufacturing.

Mercedes Scientific is a B2B distributor and supplier of laboratory consumables, reagents, and diagnostic supplies serving clinical and research laboratories, histology departments, and scientific institutions. The company stocks over 30,000 products across 20+ scientific disciplines and serves approximately 9,000 laboratories and 58,000 scientists. Core product categories include histology supplies (microscope slides, reagent alcohols, xylenes, neutral buffered formalin), phlebotomy equipment (BluDraw™ safety needles and multi-sample devices), specimen collection containers, laboratory reagents, chromatography columns, cell culture media, and diagnostic test cups (including drug screening panels). Mercedes Scientific maintains in-house brands including Mercedes Scientific® and resells products from major manufacturers such as BD, Fisher, Sigma-Aldrich, Globe Scientific, Healgen, Nest, Tanner Scientific, Restek, Wondfo, Diatron, and EK Industries. The company emphasizes knowledgeable, experienced sales support with hands-on histology and laboratory workflow expertise rather than automated call-center service. Distribution capabilities include bulk case quantities and specialized pre-filled or sterile specimen containers with temperature monitoring. Primary markets served include hospital laboratories, clinical diagnostic labs, dermatology practices, research institutions, and forensic testing facilities. The company offers online ordering with bulk discounts and a concierge service for custom supply list fulfillment.

Traceable® is a manufacturer of precision-certified laboratory instruments and environmental monitoring solutions serving healthcare, pharmaceutical, biotech, food & beverage, and industrial sectors since 1978. The company specializes in NIST-traceable calibration instruments including temperature data loggers, humidity monitors, timers, and digital meters designed for cold chain management, vaccine storage, laboratory testing, and regulated manufacturing environments. All instruments include NIST-Traceable Calibration Certificates and meet CDC and VFC compliance requirements. Traceable® also manufactures TraceableLIVE®, a cloud-based real-time environmental monitoring platform providing live condition readings, instant alerts, and remote access for freezers, laboratories, and distribution centers. The company maintains A2LA-accredited calibration services and serves critical applications requiring audit-ready documentation and strict regulatory compliance across healthcare facilities, research laboratories, pharmaceutical manufacturers, and biotech companies. Manufacturing and calibration services are supported by decades of metrological expertise and global distribution networks.

MEDTOX Diagnostics, Inc. is a point-of-care diagnostic company specializing in rapid immunoassay-based drug screening devices. The company manufactures rapid test cassettes, screening cups, and automated readers for substance abuse testing across clinical, workplace, criminal justice, and hospital settings. Primary product lines include MEDTOX PROFILE® cassettes and MEDTOX EZ-SCREEN® cups for screening up to 11 drugs of abuse with results in minutes, and the MEDTOX Scan® automated reader system for high-throughput, convenient screening. The company also offers a fentanyl test device recently cleared by FDA. MEDTOX serves hospitals, workplace wellness programs, clinical trial sponsors, and criminal justice agencies. As of 2026, the company is transitioning its trade name to Labcorp Point of Care under parent company Labcorp ownership. Products are designed for rapid point-of-care screening and typically achieve results within minutes of sample collection. The company provides training and customer support resources for clinical and administrative users.

Simple HealthKit is a healthcare infrastructure platform that delivers end-to-end solutions for member engagement, health screening programs, and connected care delivery. The company operates CLIA-certified laboratory infrastructure and provides vertically integrated screening services paired with digital patient engagement tools. Their platform serves health plans, biopharma companies, public health agencies, and retail pharmacy partners. Simple HealthKit specializes in closing HEDIS gaps, improving Star Ratings, and launching preventive care programs rapidly—typically deployable within weeks. The platform combines AI-driven digital-first tools with high-touch, at-home screening programs, supporting enrollment, screening workflows, and longitudinal patient engagement. Their enterprise-ready software integrates with existing health systems and provides real-time analytics, participation tracking, and audit-ready reporting. Clients include major health plans, insurers, retailers (Walmart, Amazon, CVS Pharmacy), state health departments, and public health organizations. The company emphasizes clinical accuracy through CLIA-certified lab operations while maintaining consumer-friendly, accessible healthcare experiences.

MPD Scientific is a laboratory instrumentation supplier based in Cranbury, New Jersey, specializing in precision instruments for research, clinical, and diagnostic applications. The company manufactures and distributes a comprehensive range of laboratory equipment including high-performance centrifuges, advanced microscopes, spectrophotometers, laboratory mixers, and associated accessories. Their product portfolio is designed for accurate sample separation, imaging, and optical analysis across diverse laboratory environments. The company serves researchers, medical facilities, and laboratory professionals worldwide, with a focus on instruments engineered for durability, efficiency, and consistent performance. MPD Scientific emphasizes quality assurance, with products rigorously tested to meet industry standards for safety and compliance. Their equipment is utilized in applications including DNA/RNA analysis, water quality monitoring, petrochemical analysis, and general laboratory diagnostics. Manufacturing capabilities include design and assembly of precision instruments with high-quality materials intended for long-term performance in demanding laboratory settings. The company maintains a worldwide distribution network via authorized representatives and distributors, providing technical support and consultation services. Marketing materials reference years of manufacturing expertise and a commitment to delivering reliable performance across a wide range of laboratory applications. The company exhibits at major industry conferences such as ADLM (Association for Diagnostics and Laboratory Medicine).

STEMCELL Technologies is a life science research company that provides innovative reagents, tools, and services for cell isolation, culture, and assay applications. The company serves academic, clinical, and industrial research laboratories globally with product portfolios spanning immunology, organoid research, hematopoietic cell research, pluripotent stem cell research, cell therapy, and neuroscience research. Their offerings include specialized cell culture media, isolation reagents, and assay tools designed for specific tissue and cell types. The company maintains dedicated scientific support services and offers training programs, including GMP-compliant Human T Cell Expansion courses. STEMCELL also provides diagnostic partnerships and OEM solutions for institutions requiring customized research reagents and protocols. Manufacturing and quality capabilities support laboratory and clinical research applications. The organization operates with a stated mission of "scientists helping scientists" and emphasizes technical expertise and customer collaboration in advancing research outcomes.

DTPM INC. is a laboratory solutions distributor and service provider serving physician offices, reference labs, recovery courts, and treatment centers across 47 US states since 1993. The company provides turnkey laboratory solutions including testing equipment, consumables, reagents, and comprehensive lab management services. DTPM offers an FDA EUA-authorized COVID-19 RT-PCR assay validated for detection of multiple SARS-CoV-2 variants including delta and omicron strains. The company distributes Solstice Advanced Materials (formerly Honeywell Research Chemicals) products including DNA/RNA purification kits applicable to bacterial, viral, and fungal samples, as well as complex matrices such as buccal swabs, saliva, respiratory samples, and blood. DTPM FreeWipes are single-ply, lint-free laboratory wipes available in bulk quantities. The company operates an online store offering analyzer consumables, collection supplies, laboratory chemicals, equipment, and general supplies from multiple manufacturers. DTPM has developed over 150 molecular assays and employs staff with 26+ years of laboratory setup experience and 30+ years of research expertise. Services include total program management for labs, dedicated technical support, point-of-care training and certification, and laboratory information systems (LIS) with online data and results management capabilities. The company focuses on high-volume routine and specialty testing, drug testing coordination with recovery and treatment programs, and customized solutions for various laboratory settings.

Associates of Cape Cod, Inc. (ACC) is a specialist manufacturer of endotoxin and glucan testing reagents, instrumentation, and software for pharmaceutical, biological product, and medical device manufacturers. The company's primary product portfolio centers on Limulus Amebocyte Lysate (LAL) reagents—derived from horseshoe crab blood—used to detect bacterial endotoxins in injectable pharmaceuticals, biologics, and medical devices. ACC also manufactures recombinant endotoxin testing (rBET) alternatives, including recombinant cascade reagents, positioning itself as a supplier of both traditional and next-generation pyrogen detection solutions. The Pyros® eXpress software platform provides integrated quantitative analysis and data management for endotoxin and glucan detection testing across glass tube and plate reader formats, with documented compatibility with Agilent BioTek Epoch 2 microplate readers. ACC operates a Contract Test Services (CTS) laboratory offering third-party endotoxin and glucan contamination testing. The company supports customers through free consultation, methodology guidance, and technical training. ACC maintains a demonstrated commitment to sustainability, including the Horseshoe Crab Sustainability Project (having reared and released over 1 million juvenile horseshoe crabs) and environmental responsibility in manufacturing. The company supplies the regulated biomedical testing market, serving manufacturers of injectable drugs, biologics, and medical devices requiring endotoxin testing for regulatory compliance (FDA, pharmacopeial).

Rocky Mountain Reagents is a manufacturer and distributor of laboratory chemicals, reagents, and supplies based in Golden, Colorado. The company operates as a direct-from-manufacturer supplier of bulk chemicals with no minimum order quantities, serving laboratories, research facilities, semiconductor manufacturers, CBD processors, and forensic operations. Product offerings include: acids and bases (nitric acid, hydrochloric acid, semiconductor-grade formulations), solvents and alcohols (HPLC-grade acetonitrile, acetone, ethanol), biological stains, buffers, indicators, titrants and standards, fine chemicals, forensic reagents, heat transfer fluids, and purification/remediation media. Laboratory supplies include glassware, plasticware, nitrile gloves (Aurelia brand), and consumables. Equipment offerings span analytical instruments (OHAUS benchtop scales), extraction equipment, lab ovens, refrigeration, pumps, and cultivation equipment. The company emphasizes in-house quality control with dedicated chemists and chemical engineers, NIST-traceable products, SDS documentation, and custom blending services. Customers cite rapid turnaround (next-day pickup capability), hands-on customer service, competitive pricing, and consistent purity standards exceeding industry specifications. The company operates two related brands: 710 SCI and Pioneer Forensics, serving specialized forensic and scientific markets.

Genesee Scientific LLC is a US-based distributor of laboratory equipment, consumables, and research supplies serving academic, clinical, and biotech laboratories. The company supplies a comprehensive portfolio of cell culture equipment, liquid handling systems, centrifugation equipment, sample agitation devices, and temperature control instruments from established brands including Poseidon, Benchmark, Eppendorf, Apex Bioresearch, FlyStuff, GenClone, Invictus, Next-Gen, Nutri-Fly, Olympus Plastics, and others. Product categories include cell culture equipment and cultureware, cell media, PCR reagents and consumables, nucleic acid extraction products, transfection reagents, liquid handling and pipette tips, tubes, centrifuges, incubators, drosophila-specific consumables and equipment, chemicals (acids, bases, solvents), gloves (including powder-free nitrile options), lab organization and storage solutions, and glassware. The company emphasizes reliable quality through curated product selection, exceptional cost efficiency via portfolio optimization, lab-centric solutions tailored to individual facility workflows, and support for scientific advancement. Genesee Scientific operates an e-commerce platform with account registration, personalized recommendations, promotional pricing programs, and order fulfillment. The company serves research institutions, academic labs, biotech firms, and clinical laboratories with consumables and equipment support.

Mossman Associates, Inc. is a medical device company that develops and distributes two primary product lines: the Biosound Therapy System and the NicCheck I urine nicotine test. The Biosound Therapy System is a vibrational therapy platform that integrates biofeedback, sound frequency healing, music therapy, and guided imagery. The system consists of a memory foam platform integrated with audio/visual delivery that utilizes precisely choreographed music synchronized with low-frequency sine tones and binaural beats. The NicCheck I is an FDA-cleared (510(k): K963733) and CLIA-waived urine dipstick test designed to measure nicotine and nicotine metabolites in clinical and professional environments. The company markets NicCheck I as the only FDA-cleared and CLIA-waived nicotine test available. Mossman Associates serves healthcare providers, clinical facilities, occupational health programs, and wellness centers. The company provides comprehensive provider resources, testimonials, research documentation, and clinical support materials for both product lines. Distribution and ordering capabilities are available through their website.

US BioTek Laboratories is a functional and integrative medicine diagnostic laboratory specializing in precision testing for naturopathic doctors, functional medicine practitioners, and integrative healthcare providers. The company operates a CLIA-certified and CAP-accredited laboratory offering comprehensive testing panels across six primary areas: Food Sensitivity Testing (IgG antibody assessment), GI Microbiome Testing (bacterial composition and metabolite analysis), Environmental Toxin Testing (mycotoxins, glyphosate, and pollutant detection), Food Allergy Testing (IgE antibody profiling), Organic Acids Testing (metabolic markers including NAD/NADH), and Hormone Testing (steroid and other hormonal markers). Their VeriTek™ quality assurance methodology emphasizes automated systems, superior assay preparation, duplicate testing protocols, and external accreditation to ensure reproducible results. The company provides collection kits with prepaid return shipping, rapid turnaround times, and results delivery via a provider portal. US BioTek serves the functional medicine and naturopathic medicine markets and recently completed a merger with NutriPATH Pathology to expand service offerings. The laboratory is positioned for practitioners seeking specialty diagnostic tools to guide precision treatment recommendations and is particularly utilized in anti-aging medicine, gastrointestinal health assessment, hormone optimization, and environmental toxicology.

MILLENSYS is a healthcare IT and business software company founded in 2008, operating from Cairo, Egypt with offices in Blairstown, New Jersey. The company delivers a unified eHealth platform ecosystem serving 14+ countries and over 49 million patients. MILLENSYS specializes in integrated clinical software solutions including Electronic Health Records (EHR), Hospital Management Information Systems (HMIS), Picture Archiving and Communication Systems (PACS), Laboratory Information Systems (LIS), Radiology Information Systems (RIS), and telemedicine platforms. The company offers enterprise imaging with vendor-neutral archive (VNA) capabilities, cloud-based PACS, teleradiology, and AI-driven diagnostic insights. MILLENSYS also provides commercial software solutions including ERP, CRM, and financial management tools for small-to-medium enterprises. Certified to international standards including IHE/HL7 and DICOM compliance, MILLENSYS serves hospitals, medical centers, clinics, and diagnostic centers with a commitment to seamless data integration, secure cloud management, and optimized operational efficiency.

IMMY is a US-based fungal diagnostics manufacturer and distributor founded in 1979, headquartered in Norman, Oklahoma. The company develops, manufactures, and distributes innovative diagnostic tests and reagents for fungal diseases affecting immunocompromised and critically ill patients. IMMY's product portfolio spans four core diagnostic platforms: (1) Lateral Flow Assays for rapid point-of-care testing (Cryptococcal Antigen, Aspergillus Galactomannan, Coccidioides Antibody); (2) Enzyme Immunoassays for high-volume laboratory settings (Histoplasma Galactomannan, Coccidioides Antibody, Blastomyces Antibody, Cryptococcal Antigen EIA); (3) Polymerase Chain Reaction assays for molecular detection of fungal pathogens (Candida auris, Candida species, Pneumocystis jirovecii); and (4) Traditional methods including Latex Agglutination, Cleargel™ Immunodiffusion, Complement Fixation, and MycoDDR specimen processing reagents. Products target endemic mycoses (histoplasmosis, coccidioidomycosis, blastomycosis, cryptococcosis) and emerging pathogens (Candida auris) in clinical reference laboratories, hospital microbiology departments, and HIV/AIDS care settings. IMMY reports impacting over 5 million lives annually, with products distributed in over 80 countries. The company operates with 100+ dedicated employees and maintains FDA clearance for its diagnostic assays. Regulatory status and ISO certifications not explicitly stated on homepage but implied through clinical adoption and international distribution.

Enterix, Inc. is a biotechnology company specializing in fecal immunochemical tests (FIT) for colorectal cancer screening and detection of lower gastrointestinal bleeding disorders. Founded in 1997 and based in Edison, NJ, the company emphasizes non-invasive, patient-friendly testing with simple at-home sample collection. Core products include InSure FIT (lab-based test for occult blood detection), InSure Quik FIT (point-of-care physician office version), and InSure One (at-home test using toilet bowl water collection via brush). All products support annual colorectal cancer screening recommendations aligned with American Cancer Society guidelines (screening starting at age 45). Enterix operates internationally with FDA clearance, CLIA waiver certification, and TGA licensing. Distribution partnerships include Quest Diagnostics and HemoCue, Inc., enabling availability through healthcare providers, pharmacies, and direct-to-consumer channels. The company prioritizes screening adherence through elimination of stool handling and sample preparation requirements.

Neelyx Labs is a CLIA-certified clinical laboratory providing end-to-end testing infrastructure and services for population health programs. The company specializes in custom-branded at-home test kit development, laboratory analysis, and digital health integration serving public health agencies, health plans, digital health companies, employers, and research organizations. Capabilities include kit design and fulfillment with prepaid return logistics, multilingual support (12+ languages), high-complexity laboratory testing with rapid turnaround (24-hour average result delivery), electronic result reporting, and chain-of-custody management. Neelyx operates a white-label laboratory model, enabling digital health companies and health plans to offer branded testing experiences while outsourcing testing operations. The company provides program design consultation, workflow optimization, regulatory navigation support, and proprietary software platforms for ordering, tracking, results delivery, and population health dashboards. Neelyx has shipped 500,000+ kits and can launch new programs in under six weeks. Service markets include community screening, disease surveillance, workplace wellness, return-to-work protocols, and clinical research. The company positions itself as mission-driven toward community health and public health priorities, with dedicated account management and full-stack operational responsibility rather than transactional mega-lab services.

JEOL Ltd. is a global manufacturer of scientific instruments, semiconductor equipment, industrial systems, and medical laboratory analyzers established in 1949. The company specializes in electron microscopy (transmission electron microscopes [TEM], scanning electron microscopes [SEM], field-emission SEMs), nuclear magnetic resonance (NMR) spectrometers, mass spectrometers (including AccuTOF-DART systems), and electron beam lithography systems for semiconductor manufacturing and research. JEOL also manufactures electron beam metal additive manufacturing (AM) systems, cross-section polishers (including the IB-19540CP and IB-19550CCP models), and clinical chemistry analyzers for laboratory applications. Primary markets include life science research (molecular biology, drug discovery, cryo-electron microscopy), semiconductor device characterization and manufacturing, materials science, industrial processing, and clinical diagnostics. The company serves universities, research institutions, semiconductor manufacturers, and medical laboratories worldwide. JEOL maintains regional operations across North America, Europe, Asia-Pacific, and the Middle East, with product lines tailored to semiconductor yield optimization, advanced materials characterization, structural biology research, and diagnostic chemistry. The company emphasizes high-resolution imaging, elemental analysis, spectroscopic capabilities, and integration of analytical workflows for research and production environments.

ML LifeSciences is a contract manufacturer specializing in custom sterile reagents and media for clinical, diagnostic, biotech, veterinary, and quality control laboratory applications. The company offers terminal sterilization, aseptic fills, universal transport media, and compounded reagents across traditional and emerging formulations. Manufacturing capabilities span the full product lifecycle: raw material sourcing, formulation, sterile manufacturing, and packaging in client-specified containers including syringes, transport vials, tubes, PVC and EVA solution bags, and polycarbonate bottles. The company serves clinicians, researchers, laboratory professionals, and diagnostic laboratories with custom solutions for QC, diagnostic, biotech, and veterinary applications. ML LifeSciences is ISO 9001 certified and maintains compliance with federal and state regulatory agencies, ensuring rigorous manufacturing standards and quality control. The company emphasizes on-time delivery, consistent product quality, and superior value for demanding and time-critical projects.

Lighthouse Worldwide Solutions (LWS) manufactures environmental monitoring (EM) systems and equipment for cleanroom contamination control across pharmaceutical, semiconductor, EV battery, and data center applications. The company specializes in real-time monitoring systems (RTMS) that integrate airborne particle counters, liquid particle counters, viable microbial samplers, and environmental sensors (temperature, pressure, humidity) into integrated platforms. LWS products include the System-In-a-Box™ (plug-and-play EM control cabinets), Apex and Solair airborne particle counters, Vertex liquid particle counters, ActiveCount viable samplers, and ScanAir handheld units. The company serves ISO Class 5 and cleaner cleanrooms in aseptic pharmaceutical manufacturing, continuous microbial monitoring for Grade A environments, semiconductor manufacturing, EV battery production, and compressed gas sampling applications. LWS provides real-time data logging, environmental out-of-tolerance alerts, and contamination control solutions mandated by GMP and regulatory standards for pharmaceutical and medical device production. The company offers consulting services for EM system design and implementation and participates in industry events including SEMIExpo and semiconductor exhibitions.

Mikron Makina is a Turkish precision manufacturing specialist established in 1982, with over 40 years of experience in high-quality medical device and component production. The company operates state-of-the-art CNC machining equipment serving the electronics, automotive, and medical device sectors. Core competencies include precision chip machining, medical implant micro-finishing under 10X microscopy, quality control via CMM and laboratory instruments, assembly and testing services, and helicoil applications. The company maintains rigorous quality standards with full traceability through Canias ERP systems, FDA compliance, and 100% customer satisfaction commitments. Mikron Makina serves as a B2B contract manufacturer and supplier for complex medical components requiring precision tolerances and regulatory compliance.

Radiation Products Design, Inc. (RPD) is a specialized manufacturer and supplier of radiation therapy, diagnostic imaging, and nuclear medicine accessories and equipment. Based in Albertville, Minnesota, RPD serves medical physics, radiation oncology, and nuclear medicine departments across the United States. The company's product portfolio spans multiple therapeutic and diagnostic domains: radiation therapy positioning and immobilization systems (thermoplastic masks, vacuum cushions, head supports, breast positioning devices); brachytherapy applicators and accessories for both low-dose rate (LDR) and high-dose rate (HDR) gynecological applications; dosimetry and quality assurance equipment including build-up caps for ion chambers (Farmer, Exradin, PTW, Scanditronix/Wellhofer models), MOSFET and diode systems, electrometers, and radiation area monitors; CT simulator and imaging accessories such as CT chambers, phantoms, marking systems, and alignment lasers; shielding products including lead blocks, eye shields, tungsten shields, and mobile radiation barriers; calibration phantoms and water phantom systems; PET/nuclear medicine workstations, storage containers, and shipping systems; and sterilization/disinfection equipment and trays. RPD manufactures custom block room products (alloy dispensers, styrofoam blocks, cooling plates), bolus materials (Aquaplast, SuperFlab, moldable options), and precision beam modification tools. The company also supplies marking and positioning consumables, measuring instruments, lead-lined containers, and quality control devices (ISIS QA phantoms, beam analyzers). Products are compatible with major linear accelerator and imaging equipment manufacturers including Varian, Siemens, and Elekta. The company maintains a comprehensive PDF catalog and offers custom manufacturing for specialized applications. RPD serves hospital radiation oncology departments, medical physics groups, nuclear medicine facilities, and diagnostic imaging centers, providing both stock products and made-to-order solutions for radiation protection, dose verification, and treatment planning.

SSI Diagnostica Group is a global leader in infectious disease clinical diagnostics, specializing in in vitro diagnostic (IVD) solutions, reagents, antisera, and quality control products. With ~600 employees across Denmark, the United States, and China, the company delivers diagnostic solutions in over 130 countries annually, serving more than 60 million people. Founded as a division of Denmark's Statens Serum Institut in the early 1900s and privatized in 2016, SSI Diagnostica now operates as a unified group comprising five portfolios: SSI Diagnostica, TECHLAB, Beijing Genesee Biotech, CTK Biotech, and Gulf Coast Scientific, combining over 200 years of combined scientific expertise. The company focuses on gastrointestinal, respiratory, bloodborne, and general microbiology diagnostics, providing rapid diagnostic tests, outbreak investigation support, and disease surveillance solutions for reference laboratories, hospitals, and healthcare professionals worldwide.

BioCheck, Inc. is a leader in value-based diagnostics and data monetization, offering high-quality in vitro diagnostic immunoassay devices. The company manufactures and distributes a comprehensive range of diagnostic products including instruments, antibodies, and ELISA kits designed for clinical and research applications. Following the August 2021 acquisition of DRG International, BioCheck operates a global network with subsidiaries and offices across the USA, Germany, Russia, Poland, and Czech Republic, providing distribution capacity to customers in over 110 countries. The DRG:HYBRiD-XL® is a fully automated analyzer for immunoassays and clinical chemistry. Product lines span diagnostic ELISAs, chemiluminescent assays, and specialized antibodies for applications including diabetes diagnosis, endocrinology, prenatal/neonatal supervision, and thyroid function testing. BioCheck emphasizes value-based diagnostics—delivering cost-effective, evidence-based diagnostic testing to improve patient outcomes and reduce unnecessary testing—alongside healthcare data monetization and shared savings models. The company aligns with well-established diagnostic principles, focusing on accessible, reliable tools for hospitals, clinics, research laboratories, and resource-limited settings.

Medline Industries, LP is the largest provider of medical-surgical products and supply chain solutions in North America, headquartered in Northfield, Illinois. With nearly 60 years of experience and over 45,000 employees globally, Medline operates 29 million+ sq ft of warehousing across 45+ U.S. distribution centers, delivering next-day service to 95% of customers. The company manufactures and distributes a comprehensive portfolio of approximately 335,000 medical-surgical products spanning all points of care—from acute care facilities to home settings. Core offerings include surgical solutions, front-line care products, laboratory and diagnostic supplies, durable medical equipment (DME), mobility aids, sterile processing and perioperative supplies, and laboratory consumables. Medline combines world-class product innovation with supply chain resilience and clinical solutions, enabling healthcare providers to improve clinical outcomes, reduce costs, and optimize operations. The company serves as a trusted manufacturing and distribution partner across hospitals, ambulatory surgery centers, long-term care facilities, and home healthcare providers.

Phamatech, Inc. is a US-based manufacturer and laboratory testing provider specializing in rapid diagnostic devices and comprehensive drug testing solutions. The company manufactures rapid diagnostic tests in-house and operates a SAMHSA- and CAP-Forensic-accredited laboratory—the only such facility in the USA performing DNA-verified urine drug testing. Service offerings include forensic drug testing, clinical drug testing, DNA-verified drug testing (U-VERIFY™), and at-home drug testing products. DNA-verified testing uses forensic analysis to match genetic markers from saliva swabs to genetic markers in urine samples, enabling unobserved remote collection and reducing tampering risks. The company tests for 70+ substances using LC-MS/MS methodology with results delivered within 72 business hours. Products include rapid diagnostic test kits (Quick Screen, EZ Home, Clear Choice) that are FDA-approved and CLIA-waived. Phamatech serves federal and state agencies, corrections departments, healthcare providers, employers, and rehabilitation programs. The laboratory operates a vertically integrated case management system providing clients with kit ordering, fulfillment tracking, and direct access to testing results. Manufacturing and testing confirmation are performed in-house at their San Diego facility, ensuring quality control and regulatory compliance at the highest certification levels including SAMHSA, CAP-Forensic, and CLIA accreditation.

Kwell Laboratories is a California-based diagnostics company specializing in rapid test kits for infectious diseases, including COVID-19, Flu, RSV, HIV, and Syphilis. The company serves as the U.S. affiliate of GenBody (Korea), importing FDA-cleared in vitro diagnostic (IVD) products and manufacturing select assays domestically. Kwell collaborates with clinical labs, clinics, nursing facilities, and medical distributors to provide point-of-care and over-the-counter testing solutions that are accessible and affordable nationwide. The company also offers private label and white-label diagnostic test kits for OEM partners and healthcare organizations committed to advancing community health through reliable, innovative diagnostic solutions.

Immudex is a life sciences reagent manufacturer specializing in flow cytometry and immune cell analysis tools for research and clinical applications. The company develops and supplies Dextramer® technology products—multimeric MHC-peptide complexes—for detection and characterization of antigen-specific T cells, B cells, non-conventional T cells, and CAR-T cells. Core product lines include MHC I and II Dextramers for flow cytometry, custom MHC allele solutions, disease-specific panels (infectious disease, autoimmunity, immuno-oncology), Klickmer® technology for next-generation sequencing and multi-omics applications, and Xynapse™ reagents for T cell activation and stimulation. The company also offers GMP-grade Dextramer® and MHC monomer reagents for clinical lot-release testing of cell therapies, supporting development of TCR-T and CAR-T immunotherapies. Immudex provides custom services including custom alleles, TCR discovery solutions, pMHC binding screening, and CAR Dextramer® development. Applications span vaccine development, cell therapy characterization, infectious disease monitoring, transplantation immune surveillance, and antibody discovery. Products are used in both academic research and pharmaceutical/biotech development. The company maintains headquarters in Virum, Denmark and a US corporate office in Fairfax, Virginia, with a visiting location in Philadelphia.

Precision BioLogic Inc. is a clinical laboratory diagnostics manufacturer specializing in frozen hemostasis reagents, controls, and specialty plasmas for coagulation and thrombophilia testing. The company produces a comprehensive portfolio of diagnostic products including: quality control plasmas (normal, abnormal, and reference controls), factor-deficient plasmas (Factors II through XII), specialty reagents for lupus anticoagulant detection, and diagnostic kits for factor assays and hemophilia testing. Key products include Chromogenic Factor VIII (bovine formulation, FDA-cleared), Chromogenic Factor IX, Hex LA, LA Check, LA Sure, and custom solutions. The company serves clinical hemostasis laboratories, hematology departments, and thrombosis centers globally. Products are supplied in frozen format, ready-to-use format eliminating reconstitution errors. The company maintains ISO 13485 certification and FDA clearance for select products. Precision BioLogic operates a customer portal for lot-specific quality control and assay certificates. The firm also publishes scientific literature and operates the Fritsma Factor educational resource for hemostasis professionals. Recent acquisition of George King Bio-Medical (October 2025) and achievement of IVDR compliance (December 2025) reflect ongoing product expansion and regulatory readiness.

Analytical Control Systems, Inc. (ACS) is a manufacturer of diagnostic controls, reagents, and quality control products for clinical laboratory and analytical testing applications. Founded in 1978, the company specializes in manufacturing stable protein and enzyme-based products in both lyophilized and liquid formats. ACS operates as an OEM manufacturer serving both laboratory reagent distributors and end-user clinical facilities. The company competes in the quality control market segment, offering proprietary formulations and manufacturing capabilities for diagnostic testing. ACS maintains a catalog of products available through distributors and direct sales channels.

DWK Life Sciences is a global manufacturer and supplier of premium laboratory glassware, primary packaging solutions, and related consumables for the life sciences industry. Formed in June 2017 from the merger of DURAN Group, Wheaton Industries, and Kimble Chase, the company operates 11–12 manufacturing sites across Europe, North America, and Asia with approximately 1,700 employees. The company maintains a portfolio of over 25,000–30,000 products under the trusted brands DURAN®, WHEATON®, and KIMBLE®. Core offerings include borosilicate laboratory glassware (bottles, vials, flasks, beakers, tubes, volumetric ware), diagnostic test packaging components, cryogenic storage vials, caps and closures, pipettes, laboratory equipment, and customized solutions. DWK provides specialized services including particulate cleaning (Ready-to-Sterilize), sterilization (Ready-to-Use), barcoding, labeling, marking, and custom secondary packaging—all designed to meet USP and European Pharmacopoeia standards. Primary markets served include drug discovery, life science research, diagnostic testing, specialty pharmaceuticals, and in vitro diagnostic manufacturing.

DCN Dx is a contract development and manufacturing organization (CDMO) and contract research organization (CRO) specializing in rapid point-of-care diagnostic tests, particularly lateral flow assays and in vitro diagnostics (IVD). Founded in 2006 and based in Carlsbad, California, DCN Dx operates a 35,000+ sq. ft. ISO 13485- and ISO 9001-compliant facility with advanced development labs including a 6,626 sq. ft. BSL-2 lab, dry room capability, and aseptic manufacturing suites. The company provides end-to-end services spanning contract assay development, custom reader design, consumable and cassette design, contract manufacturing, clinical validation, regulatory consulting, and IVD clinical trial management including trial setup, site development, biostatistics, and data management. DCN Dx also offers prospective biospecimen collection services and hosts training courses on lateral flow technology. Their multidisciplinary team works with diagnostics companies, biotech firms, and government-funded research programs to accelerate development from early-stage assay design through clinical validation and manufacturing scale-up.

True Diagnostics is a medical diagnostics developer and manufacturer specializing in innovative point-of-care and over-the-counter testing solutions. The company designs and produces diagnostic tests and devices to assist physicians in preventing, diagnosing, and treating various medical conditions. True Diagnostics' core offering is the proprietary TrueDX Cassette Technology, a patented diagnostic platform featuring internal calibration methods for flexible assay development. The TrueDX system includes a sample-handling module, integrated reaction pad with immobilized calibrators and reagents, and QR code functionality for automatic assay type detection and patient identification tracking. The cassette platform is engineered for superior shelf-life stability, simple test procedures, and reliable, cost-effective performance across over-the-counter and point-of-care markets. True Diagnostics manufactures disposable over-the-counter readers featuring LCD displays, internal calibration controls, and customizable assay detection. Their products are distributed commercially through major U.S. retailers including Walgreens and Rite Aid. The company operates as a one-stop assay developer and technology partner for organizations seeking point-of-care diagnostic solutions. True Diagnostics serves self-testing, point-of-care testing, and companion diagnostics markets, positioning itself as a provider of lab-quality results in remote and challenging testing environments.

CooperSurgical is a global leader in women's health and fertility solutions, headquartered in Trumbull, Connecticut. As a key business unit of The Cooper Companies, Inc., the company develops and distributes innovative medical devices, surgical instruments, and diagnostic tools for reproductive care, obstetrics, gynecology, and general women's health. Founded in 1990, CooperSurgical operates a 214,000-square-foot manufacturing and distribution facility in Connecticut and maintains a presence across North America, Europe, Asia-Pacific, and the Middle East. The company offers over 600 products served through multiple trusted brands, addressing healthcare needs from contraception and fertility through labor and delivery. With manufacturing expertise in molecular diagnostics, embryology systems, advanced hysteroscopy, and minimally invasive surgical technologies, CooperSurgical serves healthcare providers through direct sales, distribution networks, and comprehensive support services including preventative maintenance, product training, and spare parts availability. The company employs over 3,000 people and generates annual revenue exceeding $680 million.

Aptitude Medical Systems is a deep-tech healthcare company specializing in advanced molecular diagnostic testing platforms that deliver lab-quality results without requiring specialized laboratory infrastructure. Founded in 2011 and based in Goleta, California, the company's flagship Metrix platform enables rapid, accurate infectious disease diagnostics in multiple settings including urgent care centers, physician offices, hospitals, pharmacies, and homes. The FDA-authorized Metrix COVID-19 test provides rapid detection of COVID-19 and flu viruses using saliva or swab samples. The company is expanding its molecular testing portfolio to cover respiratory health, sexual health, and other infectious disease conditions. Aptitude's mission centers on democratizing diagnostics by making molecular-level testing accessible, affordable, and operationally simple for healthcare providers and patients globally, while addressing cost and usability challenges inherent in traditional laboratory-based diagnostics.

ENG Scientific, LLC is a B2B manufacturer and supplier of clinical laboratory stains and reagents serving hospitals, diagnostic laboratories, doctor offices, and private clinics since 1976. The company specializes in histology stains, microbiology stains, hematology reagents, cytology solutions, and specialized staining kits for tissue preparation and microbial identification. Product portfolio includes Wright-Giemsa stains, Gram stain kits, Hematoxylin stains, iron staining solutions, and buffer systems used across clinical pathology, cytopathology, hematology, and microbiology departments. ENG Scientific supplies both individual reagent solutions and complete stain kits in various volumes, serving the quality control and diagnostic needs of clinical laboratory professionals.

Diener Precision Pumps (DPP) is a custom gear pump and metering pump manufacturer serving medical, laboratory, diagnostic, and industrial markets. The company designs and manufactures precision pumps engineered in the USA with production in Switzerland (Embrach). Core product lines include gear pumps (Silencer, Optima, Extreme, Multistream series) for high-volume fluid transfer and continuous flow applications; metering/dosing pumps (Precision and Dual-Precision series) for micro-dosing in diagnostic and analytical equipment; and variable dispense pumps (Exacta series) for sensitive medical applications. DPP specializes in custom OEM solutions with minimum order volume of 100 units/year. Medical and laboratory applications include hemodialysis and peritoneal dialysis systems, laboratory and clinical diagnostics equipment, disinfection and sterilization systems for surgical instruments, and medical device fluid handling. All pumps are manufactured to tight tolerances, tested 100% pre-shipment, laser-marked for traceability, and feature advanced drive electronics for responsive flow and pressure control. The company operates an R&D facility in Lodi, California with prototype capabilities delivering samples within 2–15 days, and maintains quality certifications including NSF/ANSI 169 certification for food-service applications.

Cirdan Imaging Limited is a global provider of laboratory informatics and digital pathology solutions serving clinical pathology laboratories, hospital systems, and national laboratory networks. The company specializes in Laboratory Information System (LIS) software, digital pathology education platforms, and imaging solutions for breast biopsy and surgical pathology workflows. Cirdan's primary product, ULTRA LIS, is an advanced laboratory information system designed to streamline clinical pathways and enhance diagnostic efficiency through real-time data analysis and workflow automation. The company also offers Cirdan Tutor, a digital pathology education platform. Their imaging solutions specifically address breast biopsy, breast surgery, and pathology applications. With over 100 successful LIS installations globally and partnerships with 80 national laboratories, Cirdan serves healthcare institutions across the UK, Ireland, Australia, and Canada. The company provides 24/7/365 customer support, dedicated account management, and comprehensive e-learning resources. Cirdan's solutions are designed to optimize laboratory workflows, improve turnaround times for patient diagnosis, and support pathologists in managing core laboratory operations.

Illumina, Inc. is a global leader in DNA sequencing and array-based genomic analysis, providing comprehensive solutions for research, clinical diagnostics, and precision health applications. The company manufactures next-generation sequencing (NGS) platforms ranging from benchtop to production-scale instruments, microarray systems for genetic analysis, and library preparation kits optimized for diverse DNA and RNA workflows. Illumina's product portfolio includes the TruPath Genome solution, Single Cell 3' RNA Prep kits, and associated bioinformatics software for data analysis and insights. The company serves academic research institutions, clinical laboratories, pharmaceutical companies, and healthcare providers globally, enabling applications in cancer research, genetic disease testing, infectious disease surveillance, reproductive health, and precision medicine. Illumina offers 24/7 technical support, comprehensive documentation, training resources, and multiple financing options for instrument acquisition. The company maintains regulatory compliance with FDA clearances and international standards, and provides worldwide distribution through channel partners and direct sales. Corporate headquarters located in San Diego, CA with regional offices and support centers across North America, Europe, Asia-Pacific, and other global markets.

OPKO Health, Inc. is a diversified, publicly traded healthcare company founded in 1991 and based in Miami, Florida. Operating in over 30 countries, OPKO combines three core business segments: diagnostics, pharmaceuticals, and specialty therapeutics. BioReference Laboratories, one of the largest full-service clinical reference laboratories in the United States, serves approximately 11 million patients annually and offers comprehensive genetic testing, specialized diagnostics, and innovative testing platforms including the 4Kscore Test for prostate cancer detection. The pharmaceutical division focuses on research and development of next-generation therapies, particularly multispecific antibodies targeting cancers and infectious diseases. OPKO's marketed therapies include NGENLA™, an FDA-approved human growth hormone for pediatric growth hormone deficiency (partnered with Pfizer and approved in over 40 markets), and RAYALDEE® for secondary hyperparathyroidism treatment. The company maintains strategic partnerships with leading global organizations including Pfizer, Merck, NIH, BARDA, and Duke University, supporting its commitment to advancing innovative therapeutic solutions for serious medical conditions.

Catalent is a global Contract Development and Manufacturing Organization (CDMO) serving pharmaceutical, biotech, consumer health, and self-care companies. Founded in 2007 and headquartered in Tampa, Florida, the company operates over 50 sites worldwide with approximately 8,500 employees. Catalent specializes in end-to-end drug development, manufacturing, and supply chain services, leveraging advanced technologies including softgel encapsulation, Zydis Ultra oral fast-dissolve systems, and proprietary molecular optimization platforms. Core service areas include oral dose forms, biologics development and manufacturing (drug substance and drug product), cell and gene therapy, specialty dose delivery (inhalation, nasal, pulmonary systems), clinical supply chain management, and self-care product development. The company provides comprehensive analytical chemistry, formulation development, bioavailability studies, regulatory support, clinical packaging, comparator sourcing, and distribution logistics. Catalent has a proven track record supporting FDA approvals and commercial product launches across multiple therapeutic areas.

Veracyte is a global molecular diagnostics company specializing in genomic testing for cancer diagnosis, risk stratification, and treatment guidance. Founded in 2006 and headquartered in South San Francisco with operations in Austin, Texas, and Haifa, Israel, the company has impacted over 800,000 patients through its evidence-based portfolio of gene expression and genomic sequencing classifiers. Veracyte's core platform integrates transcriptomics, genomics, AI-assisted bioinformatics, and clinical outcome data to deliver actionable insights for thyroid, prostate, breast, bladder, and lung cancers. Key validated tests include Afirma (thyroid nodule classification), Decipher (prostate and bladder genomic assessment), and Prosigna (breast cancer risk of recurrence). The company's diagnostic innovation engine supports both LDT laboratory developed tests and collaborative R&D with biopharmaceutical partners, backed by >600 peer-reviewed publications and >35 prospective clinical trials.

Bio SB, Inc. is an FDA-registered and ISO 13485:2016 certified biotechnology manufacturer specializing in research, development, production, and distribution of antibodies and detection systems for molecular pathology. The company offers IVD validated monoclonal antibodies (rabbit and mouse), detection systems (ImmunoDetector, PolyDetector), and in situ hybridization technologies (FISH, CISH) for immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), and related diagnostic applications. Bio SB also manufactures automated staining equipment (TintoStainer Plus, TintoDetector) and tissue/cell line microarrays for cancer diagnostics, microbiology, immunology, and genetics research. The company serves biomedical laboratories, research institutions, and clinical settings globally, manufactured to FDA QSR 21 CFR Part 820 cGMP and CE IVD standards.

GeminiBio is a biotechnology company founded in 1985, specializing in cell culture solutions and process liquids for the global biotechnology industry, with applications in cell and gene therapy, biotechnology research, and academic research. Operating from a 57,000 square-foot cGMP manufacturing facility in West Sacramento, California, the company is ISO 13485 certified and FDA registered as a Class 1 Medical Device Manufacturer. GeminiBio produces two core product categories: Cell Culture Solutions (including human serum AB, fetal bovine serum, and other animal sera) and Process Liquid Solutions (custom manufacturing of media, buffers, and high-purity water). The company offers Water for Injection (WFI) quality water, purified water, and custom buffer manufacturing in segregated animal origin-free and animal component facilities. Additionally, GeminiBio provides contract manufacturing and regulatory consulting services, emphasizing quality, transparency, and compliance with cGMP standards to support the discovery, development, and commercial production of transformative biotherapeutics.

BTNX Inc. is a leading biotechnology company established in 1996, headquartered in Pickering, Ontario, Canada. Specialized in point-of-care diagnostic solutions, BTNX develops, manufactures, and distributes advanced in-vitro diagnostic tests for laboratories, clinics, and hospitals worldwide. The company's Rapid Response® product line includes rapid diagnostic tests for infectious diseases (COVID-19, influenza), drug screening (fentanyl, xylazine, medetomidine), urinalysis, women's health, and cancer screening. BTNX also manufactures harm reduction testing kits and develops HL7/POCT1-A2 compliant IT systems for test result management. All products are manufactured in ISO 13485:2016 MDSAP-certified facilities and meet CE and FDA standards. The company's diagnostic portfolio reaches over 135 countries and serves healthcare providers, laboratories, and community organizations with both clinical and forensic-use testing solutions.

MedSupply Partners is a specialized distributor of laboratory equipment, consumables, and scientific products serving biotechnology, research, and clinical laboratories since 2003. The company supplies a comprehensive range of items including pipetting systems, centrifuges, cryogenic storage solutions, PCR plates, tissue culture products, molecular biology reagents, protective apparel, and infection control supplies. Their product portfolio spans from bench-top laboratory equipment (digital pipette controllers, mini centrifuges, water baths) to consumables (serological pipets, filter tips, culture dishes, biohazard disposal containers) and reagents (fetal bovine serum, DNA extraction kits). MedSupply Partners emphasizes quality and service reliability for research institutions, diagnostic laboratories, and biotech operations.

Lords Mark Industries Ltd. is a diversified Indian conglomerate based in Mumbai, founded in 1998, with 27+ years of experience in healthcare, diagnostics, renewable energy, and sustainable solutions. Through its LordsMed division, the company manufactures GMP-WHO compliant in vitro diagnostics (IVD) and medical devices including rapid diagnostic kits, serology tests, biochemistry analyzers, and IVD instruments. The company operates a 20,000 sq ft advanced manufacturing facility and is developing AI-based diagnostic solutions, including breast cancer detection technology in collaboration with CMET. Beyond diagnostics, Lords Mark produces N95 masks, face shields, nitrile gloves, hand sanitizers, and other infection control products. The company is recognized by DGS&D as a best quality supplier and serves government and global healthcare markets.

Alta Diagnostics, Inc., established in 1989, manufactures and supplies liquid ready-to-use chemistry controls and standards for clinical laboratories, reference laboratories, universities, and military facilities across the USA and Canada. The company specializes in liquid control products that offer an open vial stability of eighteen months, eliminating reconstitution requirements and extending shelf life compared to traditional lyophilized controls. Alta Diagnostics serves hospital laboratories and reference labs with quality-assured liquid chemistry controls designed for clinical diagnostics and laboratory testing applications. The company emphasizes customer service through dedicated account executives and maintains an active research and development program to innovate product lines and manufacturing processes.

Cytiva is a global leader in bioprocessing technologies, tools, and services for biopharmaceutical manufacturing. The company specializes in modular biologics manufacturing platforms (KUBio, FlexFactory) designed to meet cGMP standards and deployable in approximately 18 months. Core offerings include chromatography resins, single-use technologies, and downstream/upstream processing solutions for vaccine development, monoclonal antibodies (mAbs), mRNA therapeutics, cell therapy, and viral vector manufacturing. Cytiva provides comprehensive support across the biopharmaceutical value chain: process development services (Fast Trak), bioprocessing digital tools, regulatory compliance resources, training programs, and technical documentation. The company emphasizes sustainability through eco-design and circular economy practices, and actively collaborates with research institutions and contract manufacturers globally to advance next-generation therapeutic platforms including gene therapy, CAR-T cell therapies, and biosimilars.

QMed is a wholesale medical, surgical, dental, and laboratory product distributor serving health systems, ambulatory surgical centers, physicians' offices, urgent care facilities, emergency medical services, and post-acute care providers throughout the United States and internationally. Operating from an ISO-certified 180,000+ square foot distribution center, QMed maintains over 11,000 individual SKUs including advanced wound care, respiratory equipment, IV therapy supplies, diagnostic instruments, orthopedic products, sterilization equipment, and infection control supplies. Since 1990, the company has partnered with national distributors, regional independents, and retailers to optimize supply chain efficiency, reduce total cost of goods, and enhance product portfolios through world-class sourcing capabilities and deep healthcare industry expertise.

Meril Life Sciences is a global medical device manufacturer headquartered in Vapi, Gujarat, India, and founded in 2006. The company designs and manufactures innovative medical devices across multiple therapeutic specialties including cardiovascular interventions, orthopedic implants, minimally invasive endoscopic surgery tools, surgical robotics, and diagnostics. Meril operates as a multinational enterprise with 100% subsidiaries and regional headquarters spanning North America, Europe, Asia, Africa, and Australia. The company maintains a dedicated research and development function collaborating with surgeons and medical experts worldwide to address unmet clinical needs. Meril's product portfolio includes transcatheter heart valve systems (Myval THV and variants), orthopedic solutions through its Maxx Orthopedics division, endoscopic and minimally invasive surgical instruments, and robotic surgical platforms. The organization emphasizes clinical evidence generation and professional education through Meril Academy, a global platform offering fellowship programs and knowledge-sharing initiatives for healthcare professionals. Manufacturing and distribution capabilities span multiple continents, with established compliance and regulatory frameworks for markets including the United States, European Union, and Asia-Pacific regions. The company serves hospital systems, surgical centers, and healthcare institutions globally, with particular focus on advancing surgical interventions in cancer care and cardiovascular disease management.

BioMedica Diagnostics Inc. is a specialized B2B diagnostics manufacturer founded in 1999, headquartered in Windsor, Ontario, Canada. The company operates a 49,000 sq ft ISO 13485:2016 and MDSAP-certified facility focused on thrombosis and haemostasis diagnostics. BioMedica develops and manufactures customized reagents, coagulometers, prothrombin time tests, fibrinogen assays, D-dimer assays, and over 15 portable diagnostic systems for clinical laboratory use. The company provides contract manufacturing and OEM production services, supporting research institutions, clinical laboratories, and healthcare stakeholders across 70+ countries. BioMedica combines R&D expertise with fully automated manufacturing capabilities, offering scalable solutions from pilot lot development through commercial-scale production for in vitro diagnostics, veterinary applications, and thrombotic risk assessment.

Avails Medical, Inc. is an in vitro diagnostics company founded in 2013 by Stanford University alumni and based in Menlo Park, California. The company specializes in rapid, automated antibiotic susceptibility testing (AST) technologies aimed at addressing antimicrobial resistance and improving outcomes for sepsis patients. Their innovative all-electrical biosensor platform streamlines the testing process by eliminating manual culturing steps, allowing for faster pathogen quantification and susceptibility testing directly from human specimens. The flagship product, the eQUANT™ System, is an FDA-cleared electronic biosensor that provides results in approximately 70 minutes, significantly reducing turnaround time for testing common gram-negative bacteria. This system is designed for easy integration into laboratory workflows and supports timely diagnostics, which can lead to better patient outcomes and lower healthcare costs. Each minute of diagnostic delay increases sepsis mortality risk; Avails Medical's rapid AST platform addresses the critical clinical need for accelerated antimicrobial susceptibility identification in blood culture specimens, with documented multicenter validation.

CTK Biotech, Inc. is a California-based biotechnology company specializing in the development and manufacturing of innovative point-of-care (POC) diagnostic test kits and immunodiagnostic tools for the global in vitro diagnostics (IVD) community. Founded in 1997, CTK manufactures portable, easy-to-use rapid diagnostic tests that enable quick and accurate disease diagnosis in clinical, remote, and underserved settings. The company maintains in-house production of recombinant antigens and antibodies, ensuring product quality and compliance with U.S. cGMP standards and WHO approval. CTK's product portfolio includes rapid tests for influenza A/B, H. pylori, syphilis, dengue, RSV, and HIV, with multiple products achieving CE-IVDR marking. As a wholly-owned affiliate of SSI Diagnostica A/S Group, CTK employs approximately 228 personnel and generates ~$28.2M in annual revenue, serving B2B diagnostics customers worldwide.

Excelitas Technologies Corp. is a global leader in photonics, specializing in high-performance sensing, detection, and imaging solutions for biomedical, semiconductor, aerospace, and defense markets. Headquartered in Pittsburgh, PA, the company provides an extensive portfolio of photonic products including lasers, light sources, photodiodes, optical components, and integrated custom solutions. With heritage dating to the late 1800s and established as a PerkinElmer spinout in 2010, Excelitas delivers innovations spanning X-Cite fluorescence illuminators for medical diagnostics, thermal infrared sensors for thermal imaging, UV-LED curing systems for medical device manufacturing, Cermax xenon lamps, and precision optical assemblies. The company serves customers from concept through production, supporting applications in surgical visualization, laboratory automation, industrial inspection, and medical device assembly.